Photo of Megan Murray

Megan Murray, M.D., Sc.D.

Ronda Stryker and William Johnston Professor of Global Health, Harvard Medical School
Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health
Associate Professor of Medicine, Brigham and Women's Hospital
Director of Research, Global Health & Social Medicine, Harvard Medical School

Megan Murray, MD, MPH, ScD is an epidemiologist and an infectious disease physician with over 25 years of experience in the management of TB programs and TB epidemiology, as well as the transmission dynamics of emerging infectious diseases. She is a Professor of Global Health and Social Medicine and an Associate Professor of Medicine at Harvard Medical School, where she leads the Global Health Research Core, a multidisciplinary group of researchers who work with the Global Health Delivery Partnership faculty and staff to develop its mission to link research to the teaching and service activities of the Partnership. She is also a Professor of Epidemiology at Harvard School of Public Health and the Director of Research at the Brigham and Women’s Hospital Division of Global Health Equity and its sister organization, Partners In Health.  Dr. Murray has conducted field studies in Peru, Rwanda, South Africa, Ukraine, Russia and the US, and has previously worked in Kenya, Niger and Pakistan. Her current interests include identifying ways to reduce the suffering caused by the health impacts of climate change, especially in low and middle income countries.

Address: 
Department of Global Health and Social Medicine
641 Huntington Avenue
Boston, MA 02115

Alternative email address: mmurray@hsph.harvard.edu

Dr. Murray’s research focuses on host and pathogen specific determinants of TB infection, disease and treatment outcomes. Much of her research is done in collaboration with the non-governmental organization Partners in Health and its Peru-based sister organization Socios en Salud. The joint team uses bacterial and human genetic and genomic tools to identify variants of interest and to understand the mechanisms of their interactions.

In addition to her work in Peru, Dr. Murray has conducted field studies in South Africa, Russia, the US, India, Indonesia, Sierra Leone, Pakistan, Niger and Rwanda. She serves as an editor for PLoS Medicine and for the European Journal of Epidemiology. She is currently a member of the Mass Consortium for Pathogen Readiness leadership team as well as Harvard University’s Covid Monitoring Committee. She has also served on numerous other committees, including the WHO’s TB-STAG, the Stop TB MDR Working Group, Harvard University Human Subjects Committee, the University’s Pandemic Flu Advisory Committee, the Institute of Medicine committee on Gulf War and Infectious Diseases, and multiple NIH study sections.

Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis.
Authors: Authors: Farhat MR, Shapiro BJ, Kieser KJ, Sultana R, Jacobson KR, Victor TC, Warren RM, Streicher EM, Calver A, Sloutsky A, Kaur D, Posey JE, Plikaytis B, Oggioni MR, Gardy JL, Johnston JC, Rodrigues M, Tang PK, Kato-Maeda M, Borowsky ML, Muddukrishna B, Kreiswirth BN, Kurepina N, Galagan J, Gagneux S, Birren B, Rubin EJ, Lander ES, Sabeti PC, Murray M.
Nat Genet
View full abstract on Pubmed
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.
Authors: Authors: Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM.
Nat Genet
View full abstract on Pubmed
RAPID HOME-BASED HIV TESTING TO REDUCE COSTS IN A LARGE TUBERCULOSIS COHORT STUDY.
Authors: Authors: Galea JT, Contreras C, Lecca L, Shin S, Lobatón R, Zhang Z, Calderón R, Murray M, Becerra MC.
Public Health Action
View full abstract on Pubmed
Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.
Authors: Authors: Reeves AZ, Campbell PJ, Sultana R, Malik S, Murray M, Plikaytis BB, Shinnick TM, Posey JE.
Antimicrob Agents Chemother
View full abstract on Pubmed
Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence.
Authors: Authors: Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, Shin S, Murray M, Becerra MC.
Clin Infect Dis
View full abstract on Pubmed
How does sex trafficking increase the risk of HIV Infection? An observational study from Southern India.
Authors: Authors: Wirth KE, Tchetgen Tchetgen EJ, Silverman JG, Murray MB.
Am J Epidemiol
View full abstract on Pubmed
Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.
Authors: Authors: Jacobson KR, Theron D, Kendall EA, Franke MF, Barnard M, van Helden PD, Victor TC, Streicher EM, Murray MB, Warren RM.
Clin Infect Dis
View full abstract on Pubmed
Assessing early access to care and child survival during a health system strengthening intervention in Mali: a repeated cross sectional survey.
Authors: Authors: Johnson AD, Thomson DR, Atwood S, Alley I, Beckerman JL, Koné I, Diakité D, Diallo H, Traoré B, Traoré K, Farmer PE, Murray M, Mukherjee J.
PLoS One
View full abstract on Pubmed
Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study.
Authors: Authors: Kendall EA, Theron D, Franke MF, van Helden P, Victor TC, Murray MB, Warren RM, Jacobson KR.
PLoS One
View full abstract on Pubmed
Comprehensive and integrated district health systems strengthening: the Rwanda Population Health Implementation and Training (PHIT) Partnership.
Authors: Authors: Drobac PC, Basinga P, Condo J, Farmer PE, Finnegan KE, Hamon JK, Amoroso C, Hirschhorn LR, Kakoma JB, Lu C, Murangwa Y, Murray M, Ngabo F, Rich M, Thomson D, Binagwaho A.
BMC Health Serv Res
View full abstract on Pubmed